Pfizer is at odds with two top federal agencies over COVID-19 booster shots.
Pfizer and two government agencies out of sync over booster shots. The drugmaker saying it’s ramping up efforts to develop a third dose that they hope will better protect people from variants, citing waning immunity from its coronavirus vaccine. Fighters saying it will soon publish data about a booster and submitted to the FDA european medicines agency and other regulators for emergency approval. But then in a rare move, the FDA and CDC came forward together with a different take, saying americans don’t need boosters yet and that it’s not up to companies alone to decide when they may be needed. I’m absolutely concerned about the confusion. I hope that that they can get on the same page. Former U. S. Surgeon general Dr Jerome Adams calling out the lack of coordination between the government and vaccine companies. This whiplash really is troubling to the american people but understand vaccinations are your best bet right now. They’re still incredibly effective. The drugmaker’s vaccine requires two doses to provide full immunity but for months Pfizer has been hinting at the need for a third dose, citing the possibility that immunity may weaken. Over time, the debate erupting is the delta variant is becoming the dominant variant, spreading quickly across the U. S. At cox Health in Springfield, Missouri, 90% of coronavirus patients tested have the delta variant. If we don’t get enough vaccinated, there’s going to be another variant. That’s probably worse. It’s just that’s the way, you know, that’s the way viruses work for today’s health. Minute I’m mary moloney.
